Chief executive officer and managing director Datuk Seri Koay Hean Eng said the company's high-precision manufacturing business enjoyed a breakthrough year on the back of higher technology usage worldwide and the reopening of economies.
"As a result, we received a huge bump in orders from semiconductor, E&E, and aerospace customers.
"Furthermore, the acquisition of a pharmaceutical and healthcare business also helped boost the company's earnings," he said.
He said that in FY23, the company would expand its exposure through the manufacturing of aluminium extrusion business.
Commentary Of Prospects The Group continues to benefit from the semiconductor shortage as manufacturers race to expand production capacity by establishing new facilities. As at 30 June 2022, we have secured new contracts amounting to RM798 million. Including the projects carried forward from the previous years, our total orderbook stands at RM1.9 billion, of which RM1.4 billion remains outstanding. In addition to that, we recently clinched an UHP contract worth approximately RM117 million from a customer in Singapore to undertake the bulk and specialty gas system distribution works. Leveraging on our strong track record, we aim to sustain our growth momentum by continuing our active participation in project tenders across our Ultra High Purity, Project Engineering and General Contracting Segments. Prospects at the Industrial Gases division remain positive as demand for liquid carbon dioxide (LCO2) increase in tandem with the recovery in economic activities. Barring unforeseen circumstances, we are confident of delivering a commendable financial performance in the second half of FY2022 as we execute our existing orderbook across our key operating markets.